eribaxaban

Ligand id: 7408

Name: eribaxaban

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 90.98
Molecular weight 484.13
XLogP 3.7
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
(2R,4R)-N-(4-chlorophenyl)-N'-[2-fluoro-4-(2-oxopyridin-1-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide
International Nonproprietary Names
INN number INN
8935 eribaxaban
Synonyms
PD-0348292
Database Links
CAS Registry No. 536748-46-6
ChEMBL Ligand CHEMBL476186
DrugBank Ligand DB06920
PubChem CID 11634458
RCSB PDB Ligand 230
Search Google for chemical match using the InChIKey QQBKAVAGLMGMHI-WIYYLYMNSA-N
Search Google for chemicals with the same backbone QQBKAVAGLMGMHI
Search PubMed clinical trials eribaxaban
Search PubMed titles eribaxaban
Search PubMed titles/abstracts eribaxaban
Search UniChem for chemical match using the InChIKey QQBKAVAGLMGMHI-WIYYLYMNSA-N
Search UniChem for chemicals with the same backbone QQBKAVAGLMGMHI
SynPHARM 80504 (in complex with coagulation factor X)
Comments
Eribaxaban is a Pfizer experimental anticoagulant which targets activated factor X (FXa) [1,3]. It has reached Phase 2 for prevention of venous thromboembolism in knee replacement